ClinicalTrials.govpublic full text
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
chronic inflammatory demyelinating polyradiculoneuropathy, nmo spectrum disorder, myasthenia gravis, idiopathic inflammatory myopathies, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1029969
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.